Burkitt's lymphoma treatment cost in the Republic of Korea typically involves specialized diagnostics such as a consultation with a hematologist ranging from $100 to $300. Primary treatment protocols like chemotherapy run from $2,800 to $8,500, while complex bone marrow transplantation costs $55,000 to $118,000. Final expenses depend on the regimen intensity, required inpatient stays, and clinic tier. Patients often save approximately 40-60% compared to the US. Top treatment centers are primarily located in Seoul.
Typical Burkitt's Lymphoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients requiring high-intensity protocols should prioritize large multidisciplinary centers like Asan Medical Center for its scale. For those seeking digital safety and electronic data management, Seoul National University Bundang Hospital (SNUBH) offers a specialized BESTcare system. High-success bone marrow transplants are most cost-effective at JCI-accredited facilities like Severance Hospital. Samsung Medical Center remains a top choice for presidential-standard care and advanced imaging technologies.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Chemotherapy | from $2,800 | from $2,430 | from $2,500 |
| Bone marrow transplantation | from $55,000 | from $36,000 | from $140,000 |
| Autologous bone marrow transplantation | from $42,000 | from $31,500 | from $50,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $145,000 | from $80,000 | from $180,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Burkitt"s lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Burkitt"s lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Burkitt"s lymphoma treatment journey.
The doctor heads the Division of Hematology-Oncology and graduated from Seoul National University College of Medicine.
Specializes in lung cancer, head and neck cancer, and esophageal cancer. Holds memberships in several prestigious organizations, including the Korean Medical Association, American Society of Clinical Oncology, and the European Society of Medical Oncology.
Dr. Dong Hyeon Lee is a hematologist-oncologist at Ewha Womans University Medical Center in Seoul. He specializes in bone marrow transplantation, including alternate donor and mismatched transplants. Dr. Lee treats colon cancer, myeloma, and lymphoma. He is a member of multiple professional oncology societies.
Standard treatment for Burkitt lymphoma in South Korea involves intensive, short-duration chemoimmunotherapy. Protocols like R-hyperCVAD or LMB combine rituximab with high-dose chemotherapy. Centers like Samsung Medical Center and Asan Medical Center provide these systemic treatments to manage rapid tumor growth and prevent central nervous system spread.
Bookimed Expert Insight: Patient volume is a major quality signal for this rare cancer. Asan Medical Center performs over 65,000 operations annually, while Severance Hospital serves 1,600,000 outpatients. Large Seoul-based centers offer more protocol experience than smaller clinics, which is critical for managing dose-intense chemotherapy safely.
Patient Consensus: Patients emphasize that treatment starts almost immediately after diagnosis because this cancer grows very fast. They note that the first phase is often the toughest due to the heavy hydration and strict monitoring required to protect the kidneys.
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital are the most experienced facilities for Burkitt lymphoma in South Korea. These JCI-accredited tertiary centers manage over 65,000 annual surgeries. They provide intensive chemotherapy and bone marrow transplantation for aggressive hematologic cancers.
Bookimed Expert Insight: While many search for specific lymphoma clinics, our data shows institutional volume is the best quality signal. Centers like Asan and Samsung manage over 45,000 procedures each. This massive caseload ensures 24/7 ICU backup and expertise in managing tumor lysis syndrome, which is critical for Burkitt lymphoma patients.
Patient Consensus: Patients note it's vital to choose a hospital that can start intensive treatment immediately. They often prioritize large university centers in Seoul for their specialized hematology teams and pathology review accuracy.
South Korea provides highly effective treatment for Burkitt's lymphoma through rapid diagnostics and advanced oncology protocols. Major Seoul academic centers utilize aggressive chemotherapy and bone marrow transplantation. These facilities maintain high success rates in treating complex hematologic malignancies within JCI-accredited environments.
Bookimed Expert Insight: While many countries specialize in specific cancers, South Korea stands out for hematology safety. Asan Medical Center performs over 65,000 surgeries yearly and reports a 90% success rate in organ transplants. This level of surgical and inpatient monitoring expertise is vital for managing the intensive chemotherapy required for Burkitt's lymphoma.
Patient Consensus: Patients emphasize that treatment begins much faster in Seoul centers compared to other healthcare systems. They highlight the importance of having a translator to navigate complex medical discussions at major university hospitals.
South Korean national health systems and private insurance provide extensive coverage for Burkitt's lymphoma. Programs usually cover standard chemotherapy and bone marrow transplants. However, gaps exist for newer agents, supportive care drugs, and off-label regimens. Patients must verify specific eligibility criteria and prior authorization requirements before starting treatment.
Bookimed Expert Insight: Clinics like Asan Medical Center and Severance Hospital manage massive patient volumes, often exceeding 1,000,000 annually. Their specialized billing departments are highly efficient at processing complex authorizations for high-cost lymphoma drugs. This institutional experience significantly reduces the risk of administrative delays compared to smaller, less specialized facilities.
Patient Consensus: Patients note that supportive care medications and infection prophylaxis often lead to unexpected bills. They recommend requesting a line-by-line cost estimate from the oncology department to avoid surprises.
Supportive care during intensive chemotherapy includes symptom management, infection prevention, and blood count stabilization to ensure treatment continuity. Specialists in South Korea utilize prophylactic antibiotics, growth factors like G-CSF, and blood transfusions. These measures protect immune systems and maintain organ function during aggressive Burkitt lymphoma protocols.
Bookimed Expert Insight: Leading Korean centers like Seoul National University Hospital and Asan Medical Center integrate digital safety systems into supportive care. The BESTcare system at SNUBH specifically helps prevent medication errors during complex chemo dosing. High-volume centers often manage over 10,000 daily patients, ensuring hematologists have extensive experience with rapid metabolic changes.
Patient Consensus: Patients note that supportive care is often built directly into the chemo plan from day 1. They emphasize that hospital-based care is very hands-on with near-daily lab tests and rapid medication adjustments.
Initial work-up for Burkitt lymphoma in South Korea involves immediate hematologist consultation and high-speed diagnostic staging. Teams prioritize bloodwork, bone marrow puncture with cytogenetic analysis, and imaging. Joint Commission International accredited facilities in Seoul typically begin these evaluations within 24 hours due to the disease's aggressive nature.
Bookimed Expert Insight: Leading Seoul hospitals like Asan Medical Center and Samsung Medical Center serve millions of patients annually. This high volume allows their hematology teams to process complex biopsies and molecular tests much faster than smaller centers. Patients should bring original pathology slides to avoid delays in starting chemotherapy or bone marrow transplantation protocols.
Patient Consensus: Patients note that Korean hospitals often repeat baseline tests even if they have recent results from home. Bringing translated medical summaries and original imaging discs helps the new medical team establish a comparison point quickly.
South Korean hospitals provide specialized international patient centers to manage logistics and language barriers for oncology. Facilities with JCI accreditation and KOIHA certification offer dedicated multilingual coordinators. These centers coordinate chemotherapy schedules, airport transfers, and help with medical records for complex Burkitt`s lymphoma cases.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital serve over 2 million patients each annually. This massive patient volume has forced these institutions to digitize every step of the patient journey. Our data shows that top-rated Seoul hospitals like SNUH and Asan Medical Center often treat national leaders. This high-stakes environment ensures that their logistical protocols are exceptionally refined for all international visitors.
Patient Consensus: Patients note it's important to contact the international office early to secure interpreting services for specialized oncology visits. While doctors often explain medical terms well in English, having a coordinator helps bridge communication gaps with pharmacy and ward staff.